title: [Betaxolol versus nifedipine in the treatment of essential hypertension].
authors.forename: A
authors.initials: A
authors.lastname: Steiner
authors.forename: S
authors.initials: S
authors.lastname: Hany
authors.forename: B
authors.initials: B
authors.lastname: Bättig
authors.forename: R
authors.initials: R
authors.lastname: Jenni
authors.forename: M
authors.initials: M
authors.lastname: Troesch
authors.forename: P
authors.initials: P
authors.lastname: Willimann
authors.forename: A
authors.initials: A
authors.lastname: Graf
authors.forename: F
authors.initials: F
authors.lastname: Leutenegger
authors.forename: V
authors.initials: V
authors.lastname: Angehrn
authors.forename: G
authors.initials: G
authors.lastname: Beck
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015784:Betaxolol; D001794:Blood Pressure / Q000187:drug effects; D004452:Echocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009543:Nifedipine; D015784:Betaxolol
vernacular_title: Betaxolol versus Nifedipin in der Behandlung der essentiellen Hypertonie.